Why is Vista Pharma. falling/rising?

As of 24-Sep, Vista Pharmaceuticals Ltd is currently priced at 9.71, reflecting an increase of 0.16 or 1.68%. Despite this uptick, the stock has been trading lower than its moving averages across various time frames, indicating a bearish trend. The stock has underperformed significantly over the past year, with a return of -30.19%, and has also shown a decline in net sales and operating profit over the last five years. Additionally, the company is facing operating losses and has a weak ability to service its debt, which contributes to its classification as a strong sell. The delivery volume has decreased by 7.97% against the five-day average, suggesting falling investor participation.
In the broader market context, Vista Pharmaceuticals has outperformed its sector by 2.13% today, which is a positive sign amidst its overall poor performance. However, when compared to the benchmark, the stock's one-week return of +0.62% contrasts with the Sensex's decline of -1.18%, indicating some resilience in the short term. Nonetheless, the long-term outlook remains bleak, as the stock has consistently underperformed against the BSE500 over various periods, including the last three years and one year. This combination of short-term gains against a backdrop of long-term struggles reflects the complex dynamics influencing Vista Pharmaceuticals' stock price.